Trial intelligence / Profile preview

Randomized trial comparing two materials to arrest enamel caries lesions in permanent teeth

RBR-49gqnnzCompleted

Sponsor
São Leopoldo Mandic
Start
Feb 2023
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of silver diamine fluoride and GC Fuji IX GP in carious lesion (2 arms), sponsored by São Leopoldo Mandic. Primary endpoint: Arrest of enamel caries lesions. Started Feb 2023; status: completed.

02

Drugs

silver diamine fluorideGC Fuji IX GP
03

Conditions

carious lesion

Beyond the preview

Go deeper on RBR-49gqnnz.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-49gqnnz.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call